March 12th 2009
12 mars 2009
Hyperbaric treatment for children
with autism: A multicenter, randomized, double-blind, controlled
Click here to read the article.
Hyperbaric therapy shows promise for autism treatment
Can hyperbaric oxygen therapy help autistic kids?
Hyperbaric Therapy Called Effective Against Autism
Hyperbaric treatment for autism reports significant
Reactions to the negative critics
of this study:
March 15th 2009
The conflicts of researcher Dr.
Daniel Rossignal are mentioned by Maugh, "Critics also note
that Rossignal is one of the biggest promoters of hyperbaric
oxygen therapy for autistic children and has staked his career
on obtaining positive results. The study was funded by manufacturers
of the devices, who also have a vested interest."
Many of us in the autism community have spent years reading about
Dr. Paul Offit vouching for vaccines. Usually he's described
as "head of infectious diseases, Children's Hospital of
Philadelphia," and only occasionally as the developer of
the rotavirus vaccine. The contrast is glaring....NEVER IS IT
NOTED that having been a member of ACIP and as a vaccine patent
holder, Offit "has staked his career" on the claim
that vaccines don't cause autism.
Media editor: Age of Autism
+ + + +
"Physicians, moreover, do
not see a biological rationale for why the therapy should work."
Which physicians did you ask about
this? Maybe the paper below and others that are following this
effect will help lead us to the explanation:
1: Am J Physiol Heart Circ Physiol.
2006 Apr;290(4):H1378-86. Epub 2005 Nov 18.
Stem cell mobilization by hyperbaric oxygen.
Thom SR, Bhopale VM, Velazquez
OC, Goldstein LJ, Thom LH, Buerk DG.
Institute for Environmental Medicine,
University of Pennsylvania, Philadelphia,
PA 19104-6068, USA. firstname.lastname@example.org
Ted Fogarty, MD
+ + + +
HBOT for brain-injured children
is now covered by Medicaid in about 20 states due to legal action
taken by aggressive parents of cerebral palsy children. Like
autism, CP is an hypoxic-ischemic brain-injury. All of the FDA-approved
uses for HBOT are for the treatment of hypoxic-ischemic tissue
where hypoxic is lack of oxygen and ischemic is lack of circulation--which
creates hypoxia. Virtually 100% of everything prescribed for
brain-injured children is not only off-label but so far off-label
that nothing prescribed is FDA-approved for pediatric use--which
means the standard of medical practice for cerebral
palsy and autistic children is the prescribing of medications
that are not FDA-approved for pediatric use. Therefore the off-label
use of HBOT for CP/autism is actually just the standard of medical
practice for these conditions; however, the hypocritical pediatric
neurology community demands a higher level of "proof"
of efficacy before insurance coverage is possible. The Rossignol
study is far, far more of a proof of efficacy than the pediatric
neurology community has ever produced for any of the drugs now
prescribed to these children. See MedicaidforHBOT dot com for